EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2005 • Xoma LTD /De/ • Pharmaceutical preparations • California
This Employment Agreement (“Agreement”), effective as of this 1st day of July, 2005, by and between XOMA (US) LLC (“XOMA” or the “Company”), a Delaware limited liability company with its principal office at 2910 Seventh Street, Berkeley, California, and J. David Boyle II (“Executive”), an individual residing at 5329 Broadway, Oakland, California 94618-1427.
LICENSE AGREEMENTLicense Agreement • August 8th, 2005 • Xoma LTD /De/ • Pharmaceutical preparations • New York
This License Agreement (this “Agreement”), effective as of June 20, 2005 (the “Effective Date”), is entered into by and between XOMA Ireland Limited, a company with limited liability organized under the laws of the Republic of Ireland having offices at Shannon Airport House, Shannon, County Clare, Ireland (“XOMA”), and Merck & Co., Inc., a corporation organized under the laws of the State of New Jersey having offices at One Merck Drive, Whitehouse Station, NJ 08889, U.S.A. (“Merck”).
RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT dated as of May 26, 2005 by and between CHIRON CORPORATION and XOMA (US) LLCResearch and Development Agreement • August 8th, 2005 • Xoma LTD /De/ • Pharmaceutical preparations • California
This Research, Development and Commercialization Agreement (this “Agreement”) is dated as of the 26th day of May, 2005 (the “Date of this Agreement”), by and between Chiron Corporation, a Delaware corporation having its principal place of business at 4650 Horton Street, Emeryville, California 94608 (“Chiron”), and XOMA (US) LLC, a Delaware limited liability company with offices located at 2910 Seventh Street, Berkeley, California 94710 (“XOMA”). Chiron and XOMA may each be referred to in this Agreement individually as a “Party” and collectively as the “Parties”. When used in this Agreement, capitalized terms shall have the meanings set forth in Article I.
ContractSecured Note Agreement • August 8th, 2005 • Xoma LTD /De/ • Pharmaceutical preparations • California
[*] indicates that a confidential portion of the text of this agreement has been omitted. The non-public information has been filed separately with the Securities and Exchange Commission.
